NIH held its first listening session in support of its new Biosafety Modernization Initiative on September 30, 2025. This was the first in a planned series focused on helping NIH modernize and strengthen biosafety oversight.

The NIH Videocast for that event is now available and can be accessed at: https://videocast.nih.gov/watch=57067. Additionally, stakeholders can embed an NIH Biosafety Widget on their own websites to further encourage comments (more information at: https://osp.od.nih.gov/help-modernize-and-strengthen-the-oversight-of-biosafety/).

Stay tuned for details about next engagements by subscribing to our listserv or checking https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy#tab2/.

Questions may be sent to: [email protected]

If you are not yet a subscriber to this listserv, please sign up here.   

NIH held its first listening session in support of its new Biosafety Modernization Initiative on September 30, 2025. This was the first in a planned series focused on helping NIH modernize and strengthen biosafety oversight.

The NIH Videocast for that event is now available and can be accessed at: https://videocast.nih.gov/watch=57067. Additionally, stakeholders can embed an NIH Biosafety Widget on their own websites to further encourage comments (more information at: https://osp.od.nih.gov/help-modernize-and-strengthen-the-oversight-of-biosafety/).

Stay tuned for details about next engagements by subscribing to our listserv or checking https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy#tab2/.

Questions may be sent to: [email protected]

If you are not yet a subscriber to this listserv, please sign up here.   

NIH’s Intramural Research Program (IRP) Access Planning Policy goes into effect tomorrow, October 1, 2025. This policy seeks to improve access to medical products developed from NIH-owned inventions. Starting October 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to provide the agency with an access plan, describing the steps they will take to promote patient access to any new drug, biologic, or medical device that results from the licensed invention.

Additional information about the policy, guidance, and resources can be found through the NIH Office of Technology Transfer website here: https://www.techtransfer.nih.gov/policy/access-policy. NIH will continue to work with stakeholders and communities to support effective implementation of this policy and to promote the best health outcomes for the American public.

Questions may be sent to the NIH Office of Technology Transfer at [email protected].

If you are not yet a subscriber to this listserv, please sign up here.   

On September 30, 2025, from 2:00 – 4:00 PM ET, NIH and the New England Biological Safety Association, the Mid-Atlantic Biological Safety Association, the Chesapeake Area Biological Safety Association, and the Northeast Biological Safety Association will be co-hosting a virtual listening session to obtain input from stakeholders on NIH’s recently announced initiative to modernize and strengthen biosafety oversight.

The meeting is free and open to the public but pre-registration is required. Priority registration for this listening session will be given to participants located in Region 1 of NIH’s stakeholder map. More information about the goals of the listening session, as well as a draft agenda, webcast information, and details on how to participate can be found on the meeting page of the OSP Website. 

For additional background on NIH’s biosafety initiative, click here.

Questions may be sent to [email protected].

If you are not yet a subscriber to this listserv, please sign up here.